See more : Sievi Capital Plc (SIEVI.HE) Income Statement Analysis – Financial Results
Complete financial analysis of Jin Medical International Ltd. (ZJYL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jin Medical International Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Natural Blue Resources, Inc. (NTUR) Income Statement Analysis – Financial Results
- Permian Resources Corporation (PR) Income Statement Analysis – Financial Results
- HEICO Corporation (HEI-A) Income Statement Analysis – Financial Results
- Wolftank-Adisa Holding AG (WOLF.VI) Income Statement Analysis – Financial Results
- DRB-HICOM Berhad (1619.KL) Income Statement Analysis – Financial Results
Jin Medical International Ltd. (ZJYL)
About Jin Medical International Ltd.
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 19.82M | 19.19M | 20.76M | 16.19M | 20.37M | 20.91M |
Cost of Revenue | 13.04M | 12.99M | 14.40M | 10.70M | 12.86M | 13.25M |
Gross Profit | 6.78M | 6.20M | 6.36M | 5.50M | 7.51M | 7.66M |
Gross Profit Ratio | 34.23% | 32.30% | 30.64% | 33.95% | 36.88% | 36.62% |
Research & Development | 1.54M | 1.89M | 1.57M | 1.26M | 1.13M | 1.20M |
General & Administrative | 1.92M | 1.77M | 1.67M | 1.50M | 1.60M | 1.72M |
Selling & Marketing | 453.31K | 402.01K | 489.00K | 385.09K | 381.11K | 513.10K |
SG&A | 2.37M | 2.18M | 2.16M | 1.88M | 1.98M | 2.23M |
Other Expenses | 0.00 | 244.12K | 194.98K | 123.28K | 0.00 | 0.00 |
Operating Expenses | 3.92M | 4.07M | 3.73M | 3.14M | 3.11M | 3.33M |
Cost & Expenses | 16.95M | 17.06M | 18.13M | 13.84M | 15.96M | 16.59M |
Interest Income | 0.00 | 181.61K | 0.00 | 0.00 | 0.00 | 25.24K |
Interest Expense | 0.00 | 0.00 | 9.49K | 112.40K | 22.85K | 0.00 |
Depreciation & Amortization | 225.90K | 357.27K | 341.25K | 324.93K | 344.04K | 368.26K |
EBITDA | 3.09M | 3.10M | 3.23M | 2.79M | 4.49M | 4.60M |
EBITDA Ratio | 15.61% | 12.02% | 15.28% | 17.34% | 23.31% | 21.98% |
Operating Income | 2.87M | 2.13M | 2.63M | 2.35M | 4.40M | 4.23M |
Operating Income Ratio | 14.47% | 11.10% | 12.67% | 14.54% | 21.62% | 20.22% |
Total Other Income/Expenses | 354.68K | 612.11K | 248.85K | -1.52K | -276.61K | 71.02K |
Income Before Tax | 3.22M | 2.74M | 2.88M | 2.35M | 4.13M | 4.30M |
Income Before Tax Ratio | 16.25% | 14.29% | 13.87% | 14.53% | 20.26% | 20.56% |
Income Tax Expense | 343.71K | 36.11K | 248.64K | 147.15K | 479.63K | 616.88K |
Net Income | 2.88M | 2.71M | 2.63M | 2.21M | 3.65M | 3.68M |
Net Income Ratio | 14.52% | 14.10% | 12.67% | 13.62% | 17.91% | 17.61% |
EPS | 0.40 | 0.34 | 0.33 | 0.28 | 0.46 | 0.01 |
EPS Diluted | 0.40 | 0.34 | 0.33 | 0.28 | 0.46 | 0.01 |
Weighted Avg Shares Out | 7.26M | 8.00M | 8.00M | 8.00M | 8.00M | 400.01M |
Weighted Avg Shares Out (Dil) | 7.26M | 8.00M | 8.00M | 8.00M | 8.00M | 400.00M |
Construction of JinMed's New Facility Begins in Chuzhou, China
ZJYL Sees a Stock Surge of 5.04% Amid Positive Financial Performance
Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Why Is Jin Medical International (ZJYL) Stock Moving Today?
Take Profit: 3 Stocks to Sell That Are Up More Than 500% in 2023
JIN MEDICAL INTERNATIONAL LTD. Enters into Memorandum of Understanding to Acquire Medical Equipment Sharing Platform
JIN MEDICAL INTERNATIONAL LTD. Empowers "Lao Le Hui" Assisted Bathing Project with Portable Nano-thermal Therapy Bath
JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment
Jin Medical International Limited Receives NASDAQ Notification Letter Regarding Noncompliance with Continued Listing Rule 5550(a)(3)
Jin Medical (NASDAQ: ZJYL) Expands into the Manufacturing Field of lifestyle Beauty Products, Collaborates in Research and Development of Three Beauty and Body Products, Securing Market Orders
Source: https://incomestatements.info
Category: Stock Reports